P14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck

Cancer

Volumn 117, Issue 6, 2011, Pages 1227-1235

  Zhang, Yang ^a,b   Sturgis, Erich M ^a   Zafereo, Mark E ^a   Wei, Qingyi ^a   Li, Guojun ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

genetic susceptibility; p14ARF; polymorphism; second primary malignancy; squamous cell carcinoma of head and neck

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYCLIN DEPENDENT KINASE INHIBITOR 2A GENE; DISEASE FREE SURVIVAL; ENDOMETRIUM CARCINOMA; ESOPHAGUS CANCER; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HYPOPHARYNX CANCER; KIDNEY CARCINOMA; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MAXILLA SINUS CARCINOMA; MOUTH CANCER; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SARCOMA; SECOND CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; THYROID PAPILLARY CARCINOMA; ADOLESCENT; AGED; CARCINOMA; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; HOSPITALIZATION; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NEOPLASMS, SQUAMOUS CELL; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TUMOR SUPPRESSOR PROTEIN P14ARF; YOUNG ADULT;

EID: 79952384675     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25605     Document Type: Article

References (36)

1. Ferlay J, Bray F, Pisani P, Parkin D., GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon, France: IARC Press; 2004.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ., Cancer statistics. 2009. CA Cancer J Clin. 2009; 59: 225-249.
3. Surveillance, Epidemiology and Results (SEER) Program. SEER Stat Database-SEER 9 Registries. SEER Cancer Statistics. Bethesda, MD: Surveillance Research Program, National Cancer Institute; July 2010 release, based on the November 2009 submission (1973-2007). Accessed July 20, 2010.
4. Sturgis EM, Miller RH., Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol. 1995; 104: 946-954.
5. Rennemo E, Zatterstrom U, Boysen M., Impact of second primary tumors on survival in head and neck cancer: an analysis of 2063 cases. Laryngoscope. 2008; 118: 1350-1356.
6. Yamamoto E, Shibuya H, Yoshimura R, Miura M., Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer. 2002; 94: 2007-2014. (Pubitemid 34270054)
7. Day GL, Blot WJ, Shore RE, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst. 1994; 86: 131-137. (Pubitemid 24040152)
8. Do KA, Johnson MM, Lee JJ, et al. Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer. 2004; 101: 2837-2842. (Pubitemid 39603192)
9. Wu X, Spitz MR, Lee JJ, et al. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants. Cancer Prev Res. 2009; 2: 617-624.
10. Gal TJ, Huang WY, Chen C, Hayes RB, Schwartz SM., DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope. 2005; 115: 2221-2231. (Pubitemid 44391640)
11. Minard CG, Spitz MR, Wu X, Hong WK, Etzel CJ., Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer. Cancer. 2006; 106: 2636-2644.
12. Li F, Sturgis EM, Zafereo ME, et al. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck. Int J Cancer. 2009; 125: 2660-2665.
13. Zafereo ME, Sturgis EM, Aleem S, Chaung K, Wei Q, Li G., Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck. Cancer Prev Res. 2009; 2: 432-439.
14. Zafereo ME, Sturgis EM, Liu Z, Wang LE, Wei Q, Li G., Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis. 2009; 30: 997-1002.
15. Lei D, Sturgis EM, Liu Z, Zafereo ME, Wei Q, Li G., Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis. 2010; 31: 222-227.
16. Haber DA., Splicing into senescence: the curious case of p16 and p19ARF. Cell. 1997; 91: 555-558. (Pubitemid 27513645)
17. Gonzalez S, Serrano M., A new mechanism of inactivation of the INK4/ARF locus. Cell Cycle. 2006; 5: 1382-1384. (Pubitemid 44159602)
18. Gjerset RA, Bandyopadhyay K., Regulation of p14ARF through subnuclear compartmentalization. Cell Cycle. 2006; 5: 686-690.
19. Li Y, He L, Bruce A, et al. p14ARF inhibits the growth of p53 deficient cells in a cell-specific manner. Biochim Biophys Acta. 2006; 1763: 787-796. (Pubitemid 44205274)
20. Sherr CJ, Bertwistle D, Den Besten W, et al. p53-Dependent and -independent functions of the Arf tumor suppressor. Cold Spring Harb Symp Quant Biol. 2005; 70: 129-137. (Pubitemid 44124864)
21. Eymin B, Claverie P, Salon C, et al. p14ARF activates a Tip60-dependent and p53 independent ATM/ATR/CHK pathway in response to genotoxic stress. Mol Cell Biol. 2006; 26: 4339-4350. (Pubitemid 43788032)
22. Bates S, Phillips AC, Clark PA, et al. p14ARF links the tumour suppressors RB and p53. Nature. 1998; 395: 124-125. (Pubitemid 28425642)
23. Chin L, Pomerantz J, DePinho RA., The INK4a/ARF tumor suppressor: 1 gene-2 products-2 pathways. Trends Biochem Sci. 1998; 23: 291-296. (Pubitemid 28461894)
24. Leduc C, Claverie P, Eymin B, et al. p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation. Oncogene. 2006; 25: 4147-4154. (Pubitemid 44079448)
25. Ghosh A, Ghosh S, Maiti GP, et al. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit. J Pathol. 2009; 217: 408-419.
26. Weber A, Wittekind C, Tannapfel A., Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of the head and neck. Pathol Res Pract. 2003; 199: 391-397. (Pubitemid 36974824)
27. Poi MJ, Yen T, Li J, et al. Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck. Mol Carcinog. 2001; 30: 26-36. (Pubitemid 32127347)
28. Ohta S, Uemura H, Matsui Y, et al. Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107: 81-91.
29. Bradley G, Irish J, MacMillan C, et al. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma. Oncogene. 2001; 20: 654-658. (Pubitemid 32156190)
30. Hu WL, Li SJ, Liu DT, et al. Genetic variants on chromosome 9p21 and ischemic stroke in Chinese. Brain Res Bull. 2009; 79: 431-435.
31. Sun P, Zhang Z, Wan J, Zhao N, Jin X, Xia Z., Association of genetic polymorphisms in GADD45A, MDM2, and p14 ARF with the risk of chronic benzene poisoning in a Chinese occupational population. Toxicol Appl Pharmacol. 2009; 240: 66-72.
32. Warren S, Gates O., Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer. 1932; 51: 1358-1403.
33. Do KA, Johnson MM, Doherty DA, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003; 14: 131-138. (Pubitemid 36539519)
34. Hashibe M, Ritz B, Le AD, Li G, Sankaranarayanan R, Zhang ZF., Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett. 2005; 220: 185-195. (Pubitemid 40568776)
35. Lee C, Smith BA, Bandyopadhyay K, et al. DNA damage disrupts the p14ARF-B23 (nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF. Cancer Res. 2005; 65: 9834-9842. (Pubitemid 41541462)
36. Dahlstrom KR, Adler-Storthz K, Etzel CJ, et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003; 9: 2620-2626. (Pubitemid 36842105)